Comparative outcome in different dosage of intra-articular steroid injection for symptomatic osteoarthritis of hip, a randomized control trial of multicenter study

Thai Orthopedic Society for Sports Medicine (TOSSM)0 个研究点目标入组 130 人开始时间: 2022年3月1日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. primary and secondary osteoarthritis of hip in Tonnis classification 1-3 with failure conservative treatment more than 4 weeks.
•(If bilateral involvement, evaluated the main site or injection site)
•2. age between 40-80 years
•3. no history of previous hip surgery
•4. no history of hip injection within 1 year before enrollment
•5. understand well in Thai language and can made self-decision

•1. uncontrolled and poor-controlled diabetic mellitus
•2. history of infection around the hip joint
•3. osteonecrosis of hip
•4. Inflammatory hip arthritis such as Ankylosing Spondylitis, Sero-Negative Spondyloarthropathy, rheumatoid arthritis
•5. allergy to anesthetic agents or steroid
•6. pregnancy (by history taking if LMP)
•7. history of degenerative spine disease with significant radicular pain or neurological deficit
•8. evidence of osteolytic or osteoblastic lesion around the hip
•9. planning for hip replacement within 6 months

发起方

Thai Orthopedic Society for Sports Medicine (TOSSM)